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Introduction: (modified) of dry Vasa leaves. The preparation was 
Vasa  (Adhatoda  vasica)  is  a  herb  that  draws  the  based on textual reference from Bhaishajya Ratnavali 
attention because of its use in different Kalpana and  14/37 with some modification; old jaggery was used in 
almost  every  Kalpana  of  this  drug  is  available  in  place of Sita Sharkara.
classics. Though Acharya Charaka has not included it 
in shwasahara mahakashaya but in Chikitsa Sthana,  The  disease  characterized  by  breathlessness 
he  has  mentioned  that  the  flower  of  this  plant  has  precipitated by narrowing of air ways has become a 
quality to pacify kapha and pitta while Bhavamishra  global health challenge. It is partly contributed by the 
(Bhava Prakash 11/55-57) has clearly mentioned that  industries led air pollution. According to the WHO 
Vasa  has  potency  to  pacify  the  disease  Shwasa  report  the  top  five  respiratory  diseases  account  for 
(dyspnoea) but does not clarify the plant part to be  17.4%  of  all  deaths  and  13.3%  of  all  Disability 
used.  The other reasons for selecting this drug is the  Adjusted Life Years (DALYS). Asthma, because of a 
abundant and ubiquitous availability of the drug Vasa  relatively low fatality rate, draws less attention than 
throughout the year while most of the other drugs used  other respiratory conditions, despite the fact that it 
for asthma are either not available throughout year or  affects about 150 million people world wide and is the 
are costly to afford to common people. As per a quote  most prevalent chronic disease in childhood. Affliction 
given  in  Charaka  Chikitsa  Sthana  (17/81),  a  of asthma in India is in parlance with the global figures 
formulation  having  madhura  (sweet)  snigdha  and  is  a  cause  of  great  concern  among  the  health 
(unctuous) and sheeta (cold in potenecy) properties,  workers to search out an effective formulation for the 
should be administered in the diseases like Hikka -  cure of this deadly disease, thus here the disease was 
Shwasa. Avaleha Kalpana fulfills all the mentioned  selected  for  investigation  with  the  above  referred 
criteria.  Thus  in  this  study  the  formulation  Vasa  Avaleha Kalpana with following aims & objectives:
avaleha  was  selected  for  the  study  to  evaluate  its  1. To compare the efficacy of Vasa avaleha prepared   
efficacy.  Also  it  is  generally  observed  that  the  from Swarasa & Kwatha on Tamaka Shwasa.
formulation available in the market with name Vasa  2. To assess the effect of trial drugs on hematological 
avaleha  are  prepared  using  Kwatha  (decoction)  and other biochemical parameters on the patients of 
prepared from dry parts of Vasa while classically the  tamaka shwasa.
drug is mentioned to be used freshly for therapeutic 
1. Ph.D. Scholar. (Author for correspondence) purpose. Also in the original reference of Vasa avaleha 
2.Professor & H.O.D, Department of Rasa Shastra &  preparation the term "Rasa" is used which is indicative 
Bhaishajya  Kalpana  including  Drug  Research.  of  Swarasa  (extracted  juice). Thus  taking  all  these 
Institute for Post Graduate Teaching & Research in  points into consideration Vasa avaleha was selected for 
Ayurveda, Gujarat Ayurved University, Jamnagar. the  present  study  for  comparing  the  therapeutic 
3.Reader, I.M.S., Banaras Hindu University, Varanasi. efficacy  of  the  formulations  one  prepared  from 
Swarasa (as per classics) and the other from Kwatha 
Abstract: Vasa (Adhatoda vasica) is used to treat the diseases such as Shwasa, Kasa and Raktapitta 
in different dosage forms like Swarasa, Avaleha and Ghrita. Although the Avaleha Kalpana is not 
available in Brihattraya, but Gada Nigraha by Aacharya Sodhal and Bhava Prakasha have 
described its use in the form of  Avaleha to treat the diseases of  Respiratory System.
The objective of  this study is to compare the efficacy of  two types of  Vasa Avaleha prepared with either 
'Swarasa' or 'Kwatha' of  Vasa during their preparation. The outcomes were assessed on the basis of  
relief  in subjective symptoms and certain hematological parameters.
Total 35 patients were enrolled for the study. Both the groups showed highly significant results on 
cardinal symptoms like frequency, intensity and duration of  Shwasa (dyspnoea), Kasa (coughing), 
Peenasa (rhinitis) with maximum percentage in Vasa Avaleha (Swarasa). The formulations also 
shows  a  insignificant  decrease  in  haematocrit  values  which  includes  Neutrophil,  Eosinophil, 
Lymphocyte count and E.S.R.. Overall Vasa Avaleha (Swarasa) shows maximum percentage of  
improvement than the other group.
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Materials And Methods: (F)  Grouping  of  Patients:  Selected  patients  were 
randomly  divided  by  random  table  method 
(A)  Selection  of  patients:-  35  patients,  attending  into two groups viz.
outpatient and in patient departments of Rasashastra  (1) Group A - Treated with Vasa Avaleha (Shwasa)
and  Bhaishajya  Kalpana  at  the  Institute  for  (2) GroupB - Treated with Vasa Avaleha (Kwatha)
Postgraduate  Teaching  &  Research  in  Ayurveda 
hospital, fulfilling the criteria of diagnosis of Tamaka  (G) Study Intervention:
Shwasa (Asthma), were selected and divided into two  (1) Group A - Vasa Avaleha (S) - 10gm, bid with 
groups irrespective of age, sex, and religion following      Anupana- Luke warm water
simple random sampling method. The consent forms  (2) Group B - Vasa Avaleha (K) - 10 gm, bid with      
were obtained from all the studied patients after the      Anupana - Luke warm water
approval of institutional Ethical committee.
(H) Time  of Administration:  Morning    8  a.m.  & 
(B) Inclusion criteria: Evening  6 p.m. 
Patients  having  classical  signs  and  symptoms  of  All  the  trial  drugs  were  given  for  28  days  and 
Shwasa and included as patient of bronchial asthma on  assessment of improvement was done as per the criteria 
the basis of following signs & symptoms  of  diagnosis. After  that  the  patients  were  provided 
routine  ayurvedic  medicines  with  follow  up  -  Symptoms/exacerbation  (Wheeze,  cough  and 
observation for four weeks. breathlessness) greater than weekly and less than daily 
in frequency. 
(I) Diet and Restriction: Patients were advised to  - Mild persistent cases of Asthma (as per WHO GINA 
avoid  aggravating  factors  mentioned  in  ancient  Guideline) of duration more than 6 months.
literature like rice, curd etc (materials which are not 
easily digestible).  (C) Exclusion criteria: 
(1) Age more than 70 years and below than 10 
(J) Criteria for outcome assessment:- years.
1.Efficacy of trial drugs were analyzed in terms of  (2) Dyspnoea resulting from cardiac diseases.
relief produced in cardinal signs and symptoms before  (3) Patient  having  pathologies  other  than 
and after the 28-day course of treatment with the help a  Bronchial Asthma Anaemia, Eosinophilia etc 
special scoring pattern developed and filled by the  (4) Patients diagnosed as diabetic (fasting blood 
investigators on the basis of the data obtained from the  sugar > 120, presence of urine sugar).
history of the disease as given below - (5) Patients having classical sign and symptoms of 
Maha Shwasa, Urdha Shwasa and Chhinna 
(01)Frequency  of  Shwasa  Vega:  (Episodes  of  Shwasa.
dyspnoea)
0 - No attack during 1 month (D) Criteria for Diagnosis: Detailed history was taken 
1 - Frequency of attack once in a month and physical examination was done on the basis of a 
2 - Frequency of attacks once in two weeks special  questionnaire,  created  for  this  study, 
3 - Frequency of attacks once in a week incorporating almost all the signs and symptoms of the 
4 - Frequency of attacks twice in a week disease. It includes frequency, intensity and duration of 
5 - Frequency of attacks once or more than once  Shwasa (dyspnoea), Kasa (coughing), Sakapha kasa 
   in a day. (productive  cough),  Peenasa  (Rhinitis), 
Kanthodhwamsa (Irritation in throat), Parshwashool 
(02) Duration of attack: (chest pain), Ghurghurakata (Ronchi) etc along with 
0 - No episode of attacks  laboratory investigations.
1 - Attack lasting for duration of 10 minutes
2 - Attack lasting for duration of 20 minutes (E) Investigations:
3 - Attack lasting for duration of 30 minutes (1) Routine  hematological,  especially  WBC, 
4 -Attack  lasting  for  duration  of  40  minutes.  ESR, AEC and routine urine examination was 
  Require  oxygen  inhalation  and  other  carried  out  in  all  the  patients  to  assess  the 
   emergency treatment.  condition of disease and to exclude any other 
5 -Attack lasting for duration of more than 40  pathology.
   minutes (2) Biochemical investigation like Blood Sugar 
(F) carried out to exclude diabetes.
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pages 23 - 28(03) Intensity of attack: 25%  relief  were  considered  as  not  improved, 
0 - Able  to  do  routine  work  &  no  treatment  percentage relief between 26 to 50% were considered 
   intervention required. as  mild  improvement,  between  51-75%  were 
1 - Unable to do work involving little movement    considered  under  moderate  improvement.  76-99% 
& relief after local snehan (application of oil)  improvement  was  considered  under  marked 
and swedan (fomentation). improvement and 100% relief was considered under 
2 - Unable to talk lines fluently and relief after  complete remission.  
booster dose of trial drug and local snehan   
(application of oil) and swedan (fomentation) Result and Observation:
3 - Able  to  speak  single  words  properly  and  Total 35 patients were enrolled in both the groups.12 & 
   relief after nebulisation / inhaler. 17  patients  were  completed  the  study  in  Vasa 
4 - Unable to talk even single words and relief  Avaleha(S), Vasa Avaleha (K) group respectively while 
   after parenteral drug administration.  6  patients  dropped  out.  They  left  against  medical 
5 - Inability to speak and express only through  advice (Table 1).
  body  language/require  oxygen  supply  and 
   other emergency treatment. Table 2 shows that at baseline of the treatment, 100% 
patients were having Shwaskashtata (Breathlessness) 
(04) Kasa: (Cough) while Ghurghurakata (ronchi) was found in 74.3% of 
0 - No cough the patients. 60% patients were having Sa kaphakasa 
1 - Cough dry without pain (productive cough) while 34.3% patients were having 
2 - Dry cough with pain Kanthoddhwansa  (choking  and  irritation  in  throat). 
3 - Dry cough with severe pain stabbing, cutting. 31.4%  patients  were  having  Parshwashoola  (chest 
4 -Frequent  coughing  due  to  which  patient  pain) and Peenasa (rhinitis). Creptitions was found in 
  becomes unconscious/fainting. 5.7% of the patients.
(05) Kapha Nistivanam:(Expectoration of phlegm) Table 1 Total Number Of Patients Registered In Both 
0 - No Kaphanishtivanam Groups
1 - Kapha Nistivanam only in the early morning
2 - Peenasa during attack and persists for a week 
   after attack
3 - Peenasa very often without attack
4 - Peenasa always persisting
(06)Urahshula / Parshvashula: (Pain in chest / in 
flanks)
0 - No Urahshula
1 - Urahshula along with the attack Table 2 Cardinal Symptom wise Distribution
2 - Very often Urahshula even without attack but 
   relieved by local Snehana and Swedana
3 - Very often Urahshula without attack and not 
   relieved by local Snehana and Swedana
4 - Always Urahshula
(07) Kanthoddhvansanam (Irritation in throat)
0 - No Kanthoddhvansanam
1 -Occasional Kanthoddhvansanam
2 -Very often Kanthoddhvansanam
3 -Always Kanthoddhvansanam
Table 3 Effect Of Drugs On Frequency Of Dyspnoea
1. Effect of trial drugs on WBC count, AEC, ESR were 
also analyzed statistically following student - t test 
(unpaired). 
2. Overall effect of therapy was evaluated on the basis 
of the percentage of relief obtained in the cardinal signs 
ad symptoms of the disease. Patients having less than  ** - Highly significant     ↓ - Decrease  
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Table 4 Effect of Drugs on Intensity of Dyspnoea Table 9 Effect on Emergency Medicine
** - Highly significant     ↓ - Decrease  
** - Highly significant     ↓ - Decrease
Table 5 Effect of Drugs on Duration of Dyspnoea
Table 10 Effect of Vasa Avaleha (s) on Haematocrit 
Values
** - Highly significant     ↓ - Decrease  
Table 6 Effect of Drugs on Kasa
Table 11 Effect of Vasa Avaleha (k) on 
Haematocrit Values
** - Highly significant     ↓ - Decrease
Table 7 Effect of Drugs on Sakapha-kasa
Table 12 Comparative Effect of Both The Drug In 
Cardinal Symptoms
** - Highly significant     ↓ - Decrease
Table 8 Effect of Drugs on Peenasa
** - Highly significant     ↓ - Decrease
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The  data  shows  that  highly  significant  (p  <0.001)  percentage of marked improvement i.e. 33.3% while 
results were found in both the groups with respect to the  Vasa  Avaleha  (K)  has  shown  more  percentage  of 
effects of drugs on frequency, intensity and duration of  moderate improvement i.e. 56.25% the details is as 
dyspnoea.  But  the  percentage  change  was  more  in  follows. The comparative effects of both the groups are 
Group-A than group B (Table 3, 4, 5). given in graph 01.
The  effect  on  Kasa  was  also  highly  significant  Discussion:
(p<0.001) in both the groups with a higher percentage  The effect of therapy was assessed in terms of complete 
change in Group-A (Table no 6). Similarly, the effect  remission, marked, moderate and mild improvement 
on Sakapha kasa also showed significant results in  along with unchanged. The patients were examined 
Group-A  (p<0.05)  and  Group  B  (p<0.01).  The  mainly for the relief in the cardinal symptoms and 
percentage change was more in Group-B than Group A  associated  symptoms.  The  biochemical  parameters 
unlike  in  dyspnoea  (Table  7).  Highly  significant  like Blood Sugar (F) and Hematological parameters 
(p<0.001) result was also observed on Peenasa with  like  E.S.R.,  A.E.C.  (Absolute  Eosinophil  Count), 
equal percentage relief (Table 8). The most interesting  T.L.C., D.L.C. were carried out to see the overall effect 
observation was seen in the patients who were taking  of drug on disease and effect on these parameters.
emergency medicine at the baseline, the drug shows 
significant (p<0.05) result with a decrease of 87.5% in  One third of patients (34.3%) were having chronicity of 
Group-A  while  Group-B  shows  highly  significant  more than five years. It affects the prognosis of disease. 
(p<0.001) result with a decrease of 72% (Table 9). It also changes the dose and duration of medication. In 
some of the patients it was observed that the need of 
On the haematocrit values i.e. eosinophils, lymphocyte  extra dose i.e. 30 gm/day. More chronicity indicates the 
counts and E.S.R. value, although both the test drugs  decreased lung capacity and patients having chronicity 
were showed percentage decrease but the values are  of more than one year is termed as Yapya (the term 
statistically  insignificant  but  in  case  of  neutrophill  indicates difficulty in management).
value  Group  A  drug  showed  insignificant  (p>0.1) 
decrease  while  Group  B  drug  showed  significant  Shwasakashtata was observed in 100% of the patients. 
(p<0.05) decrease (Table 10, 11).  Here Shwasakashtata includes duration, intensity, and 
frequency of Shwasa. Kasa was observed in 60% of the 
On comparing the effects of both the test formulations  patients. This indicates the dominancy of Vata in the 
on cardinal symptoms of asthma, it was observed that  disease, however in some of the patients Kasa was 
Vasa Avaleha (K) shows better results on frequency  acting  as  predisposing  factor.  Parshwashoola  was 
and  intensity  of  dyspnoea  but  it  was  statistically  associated with 31.4% of the patients. This indicates 
insignificant (p>0.1) while on the remaining symptoms  the coughing or use of accessory inter costal muscles 
Vasa Avaleha (S) has shown better results but it was  which  is  a  common  phenomenon  related  with  the 
again statistically insignificant (p>0.1) (Table 12).  patients  suffering  from  asthma.  Sakaphakasa  was 
found  in  51.4%  of  the  patient  indicating  the 
Graph 01 Comparative Effect Of Both Groups involvement of Kapha dosha in the disease.
According to Acharya Charaka the medicine having 
Vata-kapha  nashaka,  Ushna  and  Vatanulomaka 
property should be considered as best one to treat the 
Tamak Shwasa. He has also indicated that one should 
not  follow  only  Vatakaraka  and  Kaphanashaka  or 
Kaphakaraka and Vatanashaka treatment. Here while 
treating with Vasa Avaleha all these criteria can be 
obtained like Vasa has Vatakaraka and Kaphanashaka 
property,  Pippali  is  fulfilling  the  Ushna  guna  and 
Ghrita acting as Vatanulomaka. 
On  comparison  of  both  the  formulations,  as  per 
analysis  the Total  alkaloid  content  (by  Gravimetric 
Over All Effect of Therapy  method) was 0.406% w/w and 0.042% w/w for the 
A total of 48.27% moderate improvement, 24.1% mild  Vasa Avaleha (S) and Vasa Avaleha (K) respectively 
improvement, 20.68% marked improvement and 3%  due to which Vasa Avaleha (S) is more effective than 
no improvement was found while treating with both the  the Vasa Avaleha (K). 
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